BlackRock Japan’s Array Biopharma Inc ARRY Stock Holding History

BlackRock Japan’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-398	Closed	-$2K	–	1517
2015 Q4	$2K	Hold	398	–	–	﹤0.01%	1381
2015 Q3	$2K	Buy	+398	New	+$2.36K	﹤0.01%	1251

Other funds holding ARRY

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock Japan's ARRY Position: Q1 2016 in Review

BlackRock Japan sold out of Array Biopharma Inc (ARRY) in Q1 2016, closing a stake of 398 shares — an estimated $2K sold.

BlackRock Japan first reported a position in ARRY in Q3 2015 and held it in 2 quarters. The position peaked at $2K in Q4 2015. 132 funds tracked by Wall St. Rank hold ARRY as of Q1 2016.

BlackRock Japan reported no remaining Array Biopharma Inc position as of Q1 2016 after selling out during the quarter.
BlackRock Japan sold 398 Array Biopharma Inc shares in Q1 2016, an estimated $2K.
BlackRock Japan first reported a position in Array Biopharma Inc in Q3 2015 and held it in 2 quarters.
BlackRock Japan's Array Biopharma Inc position peaked at $2K in Q4 2015.
132 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2016.

Based on BlackRock Japan's 13F filing for Q1 2016, filed 10 May 2016.